← Company Directory
Ayala Pharmaceuticals
Work Here? Claim Your Company
Top Insights
  • Contribute something unique about Ayala Pharmaceuticals that may be helpful for others (ex. interview tips, choosing teams, unique culture, etc).

  • About

    Ayala Pharmaceuticals is a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for rare and aggressive cancers. Their lead product candidate, AL101, is a potent and selective inhibitor being tested in Phase II clinical trials for the treatment of adenoid cystic carcinoma. They are also developing AL102 for the treatment of desmoid tumors and have a collaboration agreement with Novartis for the treatment of multiple myeloma. Founded in 2017, Ayala Pharmaceuticals is headquartered in Rehovot, Israel.

    ayalapharma.com
    Website
    2017
    Year Founded
    35
    # of Employees
    $1M-$10M
    Estimated Revenue
    Headquarters

    Get Verified Salaries in your Inbox

    Subscribe to verified offers. You’ll get the breakdown of compensation details by email. Learn More →

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Featured Jobs

      No featured jobs found for Ayala Pharmaceuticals

    Related Companies

    • Spotify
    • Square
    • Airbnb
    • DoorDash
    • Databricks
    • See all companies ➜